RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy

被引:2
|
作者
Cheng, Fang [1 ]
He, Song [2 ]
机构
[1] Xi An Jiao Tong Univ, Sch Med, Lab Anim Ctr, Xian 710061, Peoples R China
[2] Chongqing Med Univ, Mol Med & Tumor Res Ctr, Chongqing 400016, Peoples R China
关键词
RNA interference (RNAi); Dendritic cells (DCs); siRNA; shRNA; Immunotherapy; Specific immune responses; Vaccine; WISKOTT-ALDRICH-SYNDROME; DC-SIGN; CHEMICAL-MODIFICATION; DOWN-REGULATION; IMMUNE-SYSTEM; GENE-THERAPY; IN-VITRO; SIRNA; EXPRESSION; ANTIGEN;
D O I
10.1007/s11033-009-9789-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA interference (RNAi) is a natural process by which small interfering RNA duplex directs sequencespecific post-transcriptional silencing of homologous genes by binding to its complementary mRNA and triggering its elimination. The history of RNAi has only about two decades, however, further studies have revealed that it is a potent method of gene silencing that has developed rapidly over the past few years as a result of its extensive importance in the study of genetics, molecular biology and physiology. RNAi technology has also recently yielded significant insight into dendritic cells (DCs) by helping to elucidate numerous mechanisms that regulate the development, activation and function of cells that mediate immunity. In addition, because of its ability to suppress gene expression effectively, this technique may be used to regulate the immune response for clinical purposes. As the key antigen presenting cells, DCs play a crucial part in the start of an immune response and in the enhancement and regulation of cell mediated immune reactions. The current studies indicated that targeting DCs with RNAi is a novel and effective therapeutic method for the fundamental research, and displayed great potential in clinical treatment.
引用
收藏
页码:2635 / 2644
页数:10
相关论文
共 50 条
  • [31] Clinical Adjuvant Combinations Stimulate Potent B-Cell Responses In Vitro by Activating Dermal Dendritic Cells
    Matthews, Katie
    Chung, Nancy P. Y.
    Klasse, Per Johan
    Moutaftsi, Magda
    Carter, Darrick
    Salazar, Andre M.
    Reed, Steven G.
    Sanders, Rogier W.
    Moore, John P.
    PLOS ONE, 2013, 8 (06):
  • [32] Development of a gene/drug dual delivery system for brain tumor therapy: Potent inhibition via RNA interference and synergistic effects
    Lei, Chenlu
    Cui, Yanna
    Zheng, Lin
    Chow, Pierce Kah-Hoe
    Wang, Chi-Hwa
    BIOMATERIALS, 2013, 34 (30) : 7483 - 7494
  • [33] RNA Interference based Approach to Down Regulate Osmoregulators of Whitefly (Bemisia tabaci): Potential Technology for the Control of Whitefly
    Raza, Amir
    Malik, Hassan Jamil
    Shafiq, Muhammad
    Amin, Imran
    Scheffler, Jodi A.
    Scheffler, Brian E.
    Mansoor, Shahid
    PLOS ONE, 2016, 11 (04):
  • [34] Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
    Phillips, Brett Eugene
    Garciafigueroa, Yesica
    Engman, Carl
    Trucco, Massimo
    Giannoukakis, Nick
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [35] Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
    Caiyun Liu
    Jie Zhu
    Yan Mi
    Tao Jin
    Journal of Neuroinflammation, 19
  • [36] Polymer nanoparticles for enhanced immune response: Combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells
    Heo, Min Beom
    Cho, Mi Young
    Lim, Yong Taik
    ACTA BIOMATERIALIA, 2014, 10 (05) : 2169 - 2176
  • [37] Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy
    Routy, Jean-Pierre
    Boulassel, Mohamed-Rachid
    Yassine-Diab, Bader
    Nicolette, Charles
    Healey, Don
    Jain, Renu
    Landry, Claire
    Yegorov, Oleg
    Tcherepanova, Irina
    Monesmith, Tamara
    Finke, Lothar
    Sekaly, Rafick-Pierre
    CLINICAL IMMUNOLOGY, 2010, 134 (02) : 140 - 147
  • [38] A novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells
    Porat, Yael
    Assa-Kunik, Efrat
    Belkin, Michael
    Krakovsky, Michael
    Lamensdorf, Itschak
    Duvdevani, Revital
    Sivak, Galit
    Niven, Mark J.
    Bulvik, Shlomo
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (07) : 623 - 634
  • [39] RNA Interference Gene Therapy Targeting Human Transcription Factor E2F1 Inhibits Human Retinoblastoma Cells Proliferation
    Wang Feng
    Ma Jia-Lie
    Li Hui-Ming
    Chen Xia-Fang
    Wang Yu-Fei
    Huang Qian
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2009, 36 (05) : 587 - 591
  • [40] Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference
    Chen, Swey-Shen
    Sun, Liang-Wu
    Brickner, Howard
    Sun, Pei-Qing
    CELLULAR IMMUNOLOGY, 2015, 294 (01) : 44 - 53